Researchers at the Francis Crick Institute have shown that the 'pacemaker' controlling yeast cell division lies inside the ...

Cyclin-dependent kinase 6 (CDK6) bound to the inhibitor ribociclib (detail view). Enzyme involved in cell cycle regulation and target of several antitumoral drugs. 3D rendering.

It was recently shown that a single cyclin–CDK complex is sufficient to drive mitosis in fission yeast. Here, the authors show that this complex is also sufficient for meiotic progression ...

The report assesses the active Cyclin-Dependent Kinase 9 (CDK9) Inhibitor pipeline products by developmental stage, product type, molecule type, and administration route. Scope of the report: ...

Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Cyclin-Dependent Kinase 9 (CDK9) Inhibitor - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering."Cyclin ...

Cell division is essential for the survival of all living organisms, from the simplest yeast to complex human beings.

CDK inhibitors are a type of cancer treatment - a drug such as the ones given during chemotherapy - to block this activity, inhibit this cell division, and slow the growth and spread of cancer cells.

Indole-3-Carbinol (I3C) Inhibits Cyclin-dependent Kinase-2 Function in Human Breast Cancer Cells by Regulating the Size Distribution, Associated Cyclin E Forms, and Subcellular Localization of the ...

The "Cyclin-Dependent Kinase (CDK) Inhibitors Therapeutics - Pipeline Analysis 2017" report has been added to Research and Markets' offering. The study analyzed that the CDK inhibitors ...

Researchers from Incyte Research Institute presented the discovery of a cyclin-dependent kinase 2 (CDK2) inhibitor, INCB-123667, being developed for the treatment of cyclin E dysregulated cancers.

Citation: Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in some breast cancer (2022, September 16) retrieved 16 May 2025 from https ...